Management Participants

The call was moderated by Ms. Hanishi Shah from Adfactors PR. Management participants included:

  • Mr. Arjun Lamba – Managing Director, Religare Enterprises Limited
  • Mr. Pratul Gupta – Chief Financial Officer, Religare Enterprises Limited
  • Management team of Religare Enterprises Limited and its subsidiaries
  • Mr. Ambrish Jindal – CFO, Care Health Insurance
  • Mr. Ajay Shah – Management, Care Health Insurance
  • Mr. Karthik Srinivasan – Management, Religare Finvest Limited
  • Mr. Prakash Jejani – Management (presumed for RFL)

Key Financial Figures - Consolidated (H1 FY27)

  • Total Income: ₹4,717 crores (19% YoY growth)
  • Loss After Tax: ₹145 crores
  • Net Worth: Approximately ₹3,000 crores as of September 30, 2026

Key Financial Figures - Consolidated (Q2 FY27)

  • Total Income: ₹2,390 crores
  • Total Expenses: ₹2,518 crores
  • Loss Before Tax: ₹128 crores

Key Financial Figures - Standalone REL (Q2 FY27)

  • Income: ₹3+ crores
  • Expenses: ₹16 crores
  • Loss: ₹13 crores

Key Financial Figures - Standalone REL (H1 FY27)

  • Income: ₹8 crores
  • Expenses: ₹31 crores
  • Loss: ₹23 crores

Business Segment Updates

Religare Broking Limited (RBL)
  • Market activity was subdued during the quarter with regulatory changes weighing on trading volumes
  • H1 FY27 Performance:
  • Total Income: ₹197 crores (7% growth)
  • Profit Before Tax: ₹13 crores (29% growth)
  • Assets Under Custody: ₹56,000+ crores
  • Revenue Mix: Brokerage (46%), Interest Income (32%), E-governance (10%), Depository Services & Third-party products (balance)
  • Q2 FY27 Performance:
  • Total Income: ₹97.4 crores (9% YoY growth)
  • PAT: ₹2.5 crores (broadly flat vs. ₹2.6 crores last year)
  • Consolidated Net Worth: ₹488 crores (mainly due to capital infusion)
  • Key Metrics:
  • Cash Segment Average Daily Turnover: grew from ₹274 crores to ₹320 crores YoY
  • Derivatives ADTO: rose 12%
  • Unique Traded Clients: increased marginally QoQ
  • Capital Infusion: REL infused ₹100 crores into RBL through rights issue in August 2026
  • Rating Updates:
  • CRISIL upgraded long-term rating to CRISIL BBB+ Stable from CRISIL BBB Stable
  • CRISIL upgraded short-term rating
  • CARE Ratings reaffirmed at CARE BBB+ and CARE A2
Religare Finvest Limited (RFL)
  • Resumed lending after 10 years, disbursed first loan just before Diwali
  • Product Offerings: Loans against property, business loans, and used car loans to salaried and self-employed borrowers, small business owners, and traders
  • Branch Openings (November 2026): Lucknow, Kanpur, and Noida (Uttar Pradesh)
  • Future Expansion: Tamil Nadu, Rajasthan, and Maharashtra
  • Business Approach: Secured-first retail lending, tech-led underwriting with branch-led relationships
  • Financial Position:
  • Legacy SME Book: ₹43 crores
  • H1 FY27 PAT: ₹64.5 crores
  • Net Owned Funds: ₹891 crores
  • Tangible Net Worth: ₹963 crores
  • Cash & Liquid Investments: ₹660 crores
  • Net NPA: Nil
  • CRAR: 230%+ (well above regulatory requirements)
  • Q2 FY27 Performance:
  • Total Income: ₹44.8 crores (vs. ₹20 crores in Q2 FY26)
  • PAT: ₹49 crores (vs. ₹30.8 crores in Q2 FY26)
  • Net Interest Income: ₹39.3 crores (vs. ₹18.5 crores previous year)
  • Collection Efficiency: ~100%
  • Performance driven by healthy recoveries from GNPA book
Religare Housing Development Finance Corporation Limited (RHDFCL)
  • Focus: Self-employed and informal segment customers in semi-urban markets
  • Current Operations:
  • 2,700 customers through 15 branches in 8 states
  • 57% customers self-employed
  • Over 50% have bureau scores above 700
  • Average Ticket Size: ₹11 lakhs
  • Portfolio LTV: ~46%
  • AUM: Above ₹240 crores (67% home loans, 33% loans against property)
  • Capital Position:
  • Net Worth: ₹170+ crores
  • Capital Adequacy: 117%
  • No external borrowings
  • Capital Commitment: REL committed ₹250 crores of capital to strengthen balance sheet
  • Q2 FY27 Performance:
  • Net Interest Income: ₹6.6 crores (H1)
  • Operating Expenses: ₹17 crores (H1, due to higher depreciation and technology costs)
  • Loss: ₹8 crores (Q2) vs. ₹5 crores (Q1)
  • Collection Efforts: Reduced delinquencies, brought 1+ pool down to 19%
  • Focus: Home loans for self-construction, identifying high-potential DSAs and connector partners
  • Maintains investment-grade ratings
Care Health Insurance Limited
  • Position: Second-largest standalone health insurer in India
  • H1 FY27 Performance (Ind AS basis):
  • Gross Written Premium (GWP): ₹6,897 crores (35% growth, full premium basis)
  • Retail Business Growth: 44% YoY (full premium basis)
  • Profit Before Tax: ₹392 crores (vs. ₹276 crores in H1 FY26, 42% growth)
  • Claim Ratio: 66.1% (improved by 90 bps)
  • Combined Operating Ratio: 100.5% (improved by 70 bps)
  • Return on Equity (PBT basis): 12.1% (from 10.2%)
  • Market Share: 7.3% overall, 24% within SAHI segment
  • Investment AUM: ₹12,900 crores
  • Claim Settlement Ratio: 97%
  • Capital Raising:
  • Raised ₹300 crores in Tier 2 capital during quarter
  • Raised another ₹150 crores in Tier 2 capital in October 2026
  • Business Metrics:
  • Retail Health Market Share: 12.8% (industry), 21.3% (SAHIs)
  • Multi-year Business: 18-20% of retail overall
  • Distribution Mix: Proprietary channel (47%), D2C growth (60%+)
  • Retail Persistency Rate: improved to 97% from 91%
  • Digital Transformation:
  • 99.5% policies issued digitally
  • 80% cashless claims processed within 30 minutes
  • Cashless Claim NPS: 74
  • App Installations: 13.8 million
  • Active Users: 1.2 million
  • 67% active retail customers on mobile app
  • Financial Performance (1/n basis - transition years, not comparable):
  • Showing loss due to accounting transition from October 2024 regulation change
  • Expected to normalize from October 2027 onwards
  • Solvency Position:
  • Current solvency ratio: 1.55x (calculated on I-GAAP basis)
  • Difference in net worth between I-GAAP and Ind AS: ~₹1,000+ crores
  • Planning ₹300 crores rights issue in November 2026

Corporate Governance Updates

  • RBI approved appointment of new directors: Dr. Anand Burman, Mr. Aditya Burman, Mr. Mohit Burman, and Jimeet Modi
  • These are promoter and shareholder directors
  • Corporate offices moved to Mumbai

Strategic Priorities and Guidance

  • Demerger/Restructuring: High priority item, in touch with regulators and advisors
  • Business Build-out Timeline: 24 months for full potential realization
  • RFL Growth Targets:
  • Current Year Disbursement: <₹100 crores
  • FY28 Disbursement Target: ₹1,500-1,700 crores
  • Long-term AUM Target: ₹10,000-15,000 crores over 4-5 years
  • Target ROA: 2.5-2.8%
  • Target Yield: 15.5%
  • Care Health Insurance Guidance:
  • Expect to maintain growth better than industry rates
  • Combined ratio expected to improve further
  • Awaiting IRDAI draft regulations on distribution and solvency calculation

Warrant Conversion Update

  • Total Warrants: ₹1,500 crores
  • Funds Received: ₹619 crores (25% - ₹375 crores at subscription, ₹243 crores incremental conversions over last year)
  • Remaining: ₹880 crores, maturity in March 2027
  • Funds used for infusion into Care Health Insurance (rights issue) and broking business